ad image

Enzymes

1 / 1
Enzymaster
M&A

Enzymaster’s Sanming Minhe Acquisition Increases Production Capacity by 50% to Keep Pace with Rapidly Growing Demand

Enzymaster

PR-M01-22-14Jan 20, 2022
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
Drug Development

A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways

Jonathan Reis, Ph.D.

PAP-Q1-20-CL-011Mar 19, 2020
Applying Enzymatic Synthesis for Chiral Molecules
Chiral Synthesis

Applying Enzymatic Synthesis for Chiral Molecules

Juliette Martin, Ph.D.; Sergio Kreimerman, Ph.D.

Seqens

PAP-Q2-2019-CL-029May 24, 2019
New England Biolabs
Launch

New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for Bisulfite-Free Methylation Analysis

New England Biolabs

PR-M05-19-NI-003May 01, 2019
Enzyvant
FDA Fast Track

Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations

Enzyvant

PR-M03-19-NI-073Mar 26, 2019
BridgeBio Pharma
Cell and Gene Therapy

BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders

BridgeBio Pharma

PR-M06-18-NI-052Jun 15, 2018
RNA-Modifying Proteins May Provide New Drug Targets
Drug Discovery

RNA-Modifying Proteins May Provide New Drug Targets

Guy Tiene

Nice Insight

PAO-M05-18-NI-018May 24, 2018
Almac Expands Analytical Services with BioClin Laboratories Acquisition
Acquisition

Almac Expands Analytical Services with BioClin Laboratories Acquisition

Nice Insight

PAO-M11-17-NI-033Nov 21, 2017
1 / 1